Global Parenteral Drugs Sales Market Report 2024

Report ID: 855659 | Published Date: Dec 2024 | No. of Page: 140 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Parenteral Drugs Market Overview
    1.1 Parenteral Drugs Product Scope
    1.2 Parenteral Drugs Segment 
        1.2.1 Global Parenteral Drugs Sales  (2016 & 2021 & 2027)
        1.2.2 LVP Drug
        1.2.3 SVP Drug
    1.3 Parenteral Drugs Segment 
        1.3.1 Global Parenteral Drugs Sales Comparison  (2016 & 2021 & 2027)
        1.3.2 Hospitals
        1.3.3 Medical Centers
        1.3.4 Others
    1.4 Parenteral Drugs Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Parenteral Drugs Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Parenteral Drugs Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Parenteral Drugs Price Trends (2016-2027)

2 Parenteral Drugs Estimates and Forecasts by Region
    2.1 Global Parenteral Drugs Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Parenteral Drugs Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Parenteral Drugs Sales Market Share by Region (2016-2021)
        2.2.2 Global Parenteral Drugs Revenue Market Share by Region (2016-2021)
    2.3 Global Parenteral Drugs Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Parenteral Drugs Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Parenteral Drugs Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Parenteral Drugs Estimates and Projections (2016-2027)
        2.4.2 Europe Parenteral Drugs Estimates and Projections (2016-2027)
        2.4.3 China Parenteral Drugs Estimates and Projections (2016-2027)
        2.4.4 Japan Parenteral Drugs Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Parenteral Drugs Estimates and Projections (2016-2027)
        2.4.6 India Parenteral Drugs Estimates and Projections (2016-2027)
3 Global Parenteral Drugs Competition Landscape by Players
    3.1 Global Top Parenteral Drugs Players by Sales (2016-2021)
    3.2 Global Top Parenteral Drugs Players by Revenue (2016-2021)
    3.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Drugs as of 2020)
    3.4 Global Parenteral Drugs Average Price by Company (2016-2021)
    3.5 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Parenteral Drugs Market Size 
    4.1 Global Parenteral Drugs Historic Market Review  (2016-2021)
        4.1.1 Global Parenteral Drugs Sales Market Share  (2016-2021)
        4.1.2 Global Parenteral Drugs Revenue Market Share  (2016-2021)
        4.1.3 Global Parenteral Drugs Price  (2016-2021)
    4.2 Global Parenteral Drugs Market Estimates and Forecasts  (2022-2027)
        4.2.1 Global Parenteral Drugs Sales Forecast  (2022-2027)
        4.2.2 Global Parenteral Drugs Revenue Forecast  (2022-2027)
        4.2.3 Global Parenteral Drugs Price Forecast  (2022-2027)
5 Global Parenteral Drugs Market Size 
    5.1 Global Parenteral Drugs Historic Market Review  (2016-2021)
        5.1.1 Global Parenteral Drugs Sales Market Share  (2016-2021)
        5.1.2 Global Parenteral Drugs Revenue Market Share  (2016-2021)
        5.1.3 Global Parenteral Drugs Price  (2016-2021)
    5.2 Global Parenteral Drugs Market Estimates and Forecasts  (2022-2027)
        5.2.1 Global Parenteral Drugs Sales Forecast  (2022-2027)
        5.2.2 Global Parenteral Drugs Revenue Forecast  (2022-2027)
        5.2.3 Global Parenteral Drugs Price Forecast  (2022-2027)

6 North America Parenteral Drugs Market Facts & Figures
    6.1 North America Parenteral Drugs Sales by Company
        6.1.1 North America Parenteral Drugs Sales by Company (2016-2021)
        6.1.2 North America Parenteral Drugs Revenue by Company (2016-2021)
    6.2 North America Parenteral Drugs Sales Breakdown 
        6.2.1 North America Parenteral Drugs Sales Breakdown  (2016-2021)
        6.2.2 North America Parenteral Drugs Sales Breakdown  (2022-2027)
    6.3 North America Parenteral Drugs Sales Breakdown 
        6.3.1 North America Parenteral Drugs Sales Breakdown  (2016-2021)
        6.3.2 North America Parenteral Drugs Sales Breakdown  (2022-2027)

7 Europe Parenteral Drugs Market Facts & Figures
    7.1 Europe Parenteral Drugs Sales by Company
        7.1.1 Europe Parenteral Drugs Sales by Company (2016-2021)
        7.1.2 Europe Parenteral Drugs Revenue by Company (2016-2021)
    7.2 Europe Parenteral Drugs Sales Breakdown 
        7.2.1 Europe Parenteral Drugs Sales Breakdown  (2016-2021)
        7.2.2 Europe Parenteral Drugs Sales Breakdown  (2022-2027)
    7.3 Europe Parenteral Drugs Sales Breakdown 
        7.3.1 Europe 140 Sales Breakdown  (2016-2021)
        7.3.2 Europe 140 Sales Breakdown  (2022-2027)

8 China Parenteral Drugs Market Facts & Figures
    8.1 China Parenteral Drugs Sales by Company
        8.1.1 China Parenteral Drugs Sales by Company (2016-2021)
        8.1.2 China Parenteral Drugs Revenue by Company (2016-2021)
    8.2 China Parenteral Drugs Sales Breakdown 
        8.2.1 China Parenteral Drugs Sales Breakdown  (2016-2021)
        8.2.2 China Parenteral Drugs Sales Breakdown  (2022-2027)
    8.3 China Parenteral Drugs Sales Breakdown 
        8.3.1 China 313 Sales Breakdown  (2016-2021)
        8.3.2 China 313 Sales Breakdown  (2022-2027)

9 Japan Parenteral Drugs Market Facts & Figures
    9.1 Japan Parenteral Drugs Sales by Company
        9.1.1 Japan Parenteral Drugs Sales by Company (2016-2021)
        9.1.2 Japan Parenteral Drugs Revenue by Company (2016-2021)
    9.2 Japan Parenteral Drugs Sales Breakdown 
        9.2.1 Japan Parenteral Drugs Sales Breakdown  (2016-2021)
        9.2.2 Japan Parenteral Drugs Sales Breakdown  (2022-2027)
    9.3 Japan Parenteral Drugs Sales Breakdown 
        9.3.1 Japan Feb. Sales Breakdown  (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown  (2022-2027)

10 Southeast Asia Parenteral Drugs Market Facts & Figures
    10.1 Southeast Asia Parenteral Drugs Sales by Company
        10.1.1 Southeast Asia Parenteral Drugs Sales by Company (2016-2021)
        10.1.2 Southeast Asia Parenteral Drugs Revenue by Company (2016-2021)
    10.2 Southeast Asia Parenteral Drugs Sales Breakdown 
        10.2.1 Southeast Asia Parenteral Drugs Sales Breakdown  (2016-2021)
        10.2.2 Southeast Asia Parenteral Drugs Sales Breakdown  (2022-2027)
    10.3 Southeast Asia Parenteral Drugs Sales Breakdown 
        10.3.1 Southeast Asia K Units Sales Breakdown  (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown  (2022-2027)

11 India Parenteral Drugs Market Facts & Figures
    11.1 India Parenteral Drugs Sales by Company
        11.1.1 India Parenteral Drugs Sales by Company (2016-2021)
        11.1.2 India Parenteral Drugs Revenue by Company (2016-2021)
    11.2 India Parenteral Drugs Sales Breakdown 
        11.2.1 India Parenteral Drugs Sales Breakdown  (2016-2021)
        11.2.2 India Parenteral Drugs Sales Breakdown  (2022-2027)
    11.3 India Parenteral Drugs Sales Breakdown 
        11.3.1 India Parenteral Drugs Sales Breakdown  (2016-2021)
        11.3.2 India Parenteral Drugs Sales Breakdown  (2022-2027)

12 Company Profiles and Key Figures in Parenteral Drugs Business
    12.1 Ostuka Pharmaceutical
        12.1.1 Ostuka Pharmaceutical Corporation Information
        12.1.2 Ostuka Pharmaceutical Business Overview
        12.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
        12.1.5 Ostuka Pharmaceutical Recent Development
    12.2 Teva Pharmaceutical Industries
        12.2.1 Teva Pharmaceutical Industries Corporation Information
        12.2.2 Teva Pharmaceutical Industries Business Overview
        12.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
        12.2.5 Teva Pharmaceutical Industries Recent Development
    12.3 Kelun Pharma
        12.3.1 Kelun Pharma Corporation Information
        12.3.2 Kelun Pharma Business Overview
        12.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Kelun Pharma Parenteral Drugs Products Offered
        12.3.5 Kelun Pharma Recent Development
    12.4 Cook Pharmica
        12.4.1 Cook Pharmica Corporation Information
        12.4.2 Cook Pharmica Business Overview
        12.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Cook Pharmica Parenteral Drugs Products Offered
        12.4.5 Cook Pharmica Recent Development
    12.5 Patheon
        12.5.1 Patheon Corporation Information
        12.5.2 Patheon Business Overview
        12.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Patheon Parenteral Drugs Products Offered
        12.5.5 Patheon Recent Development
    12.6 BAG Healthcare
        12.6.1 BAG Healthcare Corporation Information
        12.6.2 BAG Healthcare Business Overview
        12.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 BAG Healthcare Parenteral Drugs Products Offered
        12.6.5 BAG Healthcare Recent Development
    12.7 Beximco Pharma
        12.7.1 Beximco Pharma Corporation Information
        12.7.2 Beximco Pharma Business Overview
        12.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Beximco Pharma Parenteral Drugs Products Offered
        12.7.5 Beximco Pharma Recent Development
    12.8 Baxter Healthcare Corporation
        12.8.1 Baxter Healthcare Corporation Corporation Information
        12.8.2 Baxter Healthcare Corporation Business Overview
        12.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
        12.8.5 Baxter Healthcare Corporation Recent Development
    12.9 B. Braun
        12.9.1 B. Braun Corporation Information
        12.9.2 B. Braun Business Overview
        12.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 B. Braun Parenteral Drugs Products Offered
        12.9.5 B. Braun Recent Development
    12.10 Fresenius
        12.10.1 Fresenius Corporation Information
        12.10.2 Fresenius Business Overview
        12.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Fresenius Parenteral Drugs Products Offered
        12.10.5 Fresenius Recent Development
    12.11 Albert David
        12.11.1 Albert David Corporation Information
        12.11.2 Albert David Business Overview
        12.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Albert David Parenteral Drugs Products Offered
        12.11.5 Albert David Recent Development
    12.12 BML Parenteral Drugs
        12.12.1 BML Parenteral Drugs Corporation Information
        12.12.2 BML Parenteral Drugs Business Overview
        12.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 BML Parenteral Drugs Parenteral Drugs Products Offered
        12.12.5 BML Parenteral Drugs Recent Development
    12.13 Pfizer (Hospira)
        12.13.1 Pfizer (Hospira) Corporation Information
        12.13.2 Pfizer (Hospira) Business Overview
        12.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Pfizer (Hospira) Parenteral Drugs Products Offered
        12.13.5 Pfizer (Hospira) Recent Development
    12.14 Pisa
        12.14.1 Pisa Corporation Information
        12.14.2 Pisa Business Overview
        12.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Pisa Parenteral Drugs Products Offered
        12.14.5 Pisa Recent Development
    12.15 Ozon Pharmaceuticals Ltd
        12.15.1 Ozon Pharmaceuticals Ltd Corporation Information
        12.15.2 Ozon Pharmaceuticals Ltd Business Overview
        12.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Products Offered
        12.15.5 Ozon Pharmaceuticals Ltd Recent Development
    12.16 Aspen Holdings
        12.16.1 Aspen Holdings Corporation Information
        12.16.2 Aspen Holdings Business Overview
        12.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.16.4 Aspen Holdings Parenteral Drugs Products Offered
        12.16.5 Aspen Holdings Recent Development
    12.17 PSI Ltd
        12.17.1 PSI Ltd Corporation Information
        12.17.2 PSI Ltd Business Overview
        12.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.17.4 PSI Ltd Parenteral Drugs Products Offered
        12.17.5 PSI Ltd Recent Development
    12.18 Wintac Limited
        12.18.1 Wintac Limited Corporation Information
        12.18.2 Wintac Limited Business Overview
        12.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.18.4 Wintac Limited Parenteral Drugs Products Offered
        12.18.5 Wintac Limited Recent Development
    12.19 AXA Parenterals Ltd
        12.19.1 AXA Parenterals Ltd Corporation Information
        12.19.2 AXA Parenterals Ltd Business Overview
        12.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.19.4 AXA Parenterals Ltd Parenteral Drugs Products Offered
        12.19.5 AXA Parenterals Ltd Recent Development
    12.20 Acebright
        12.20.1 Acebright Corporation Information
        12.20.2 Acebright Business Overview
        12.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.20.4 Acebright Parenteral Drugs Products Offered
        12.20.5 Acebright Recent Development
    12.21 Southwest Pharmaceutical
        12.21.1 Southwest Pharmaceutical Corporation Information
        12.21.2 Southwest Pharmaceutical Business Overview
        12.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.21.4 Southwest Pharmaceutical Parenteral Drugs Products Offered
        12.21.5 Southwest Pharmaceutical Recent Development
    12.22 Abbott
        12.22.1 Abbott Corporation Information
        12.22.2 Abbott Business Overview
        12.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2016-2021)
        12.22.4 Abbott Parenteral Drugs Products Offered
        12.22.5 Abbott Recent Development

13 Parenteral Drugs Manufacturing Cost Analysis
    13.1 Parenteral Drugs Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Parenteral Drugs
    13.4 Parenteral Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Parenteral Drugs Distributors List
    14.3 Parenteral Drugs Customers

15 Market Dynamics
    15.1 Parenteral Drugs Market Trends
    15.2 Parenteral Drugs Drivers
    15.3 Parenteral Drugs Market Challenges
    15.4 Parenteral Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Parenteral Drugs Sales (US$ Million) Growth Rate  (2016 & 2021 & 2027)
    Table 2. Global Parenteral Drugs Sales ((US$ Million)) Comparison  (2016 & 2021 & 2027)
    Table 3. Global Parenteral Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Parenteral Drugs Sales (K Units) by Region (2016-2021)
    Table 5. Global Parenteral Drugs Sales Market Share by Region (2016-2021)
    Table 6. Global Parenteral Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Parenteral Drugs Revenue Share by Region (2016-2021)
    Table 8. Global Parenteral Drugs Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Parenteral Drugs Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Parenteral Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Parenteral Drugs Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Parenteral Drugs Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Parenteral Drugs Sales Share by Company (2016-2021)
    Table 14. Global Parenteral Drugs Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Parenteral Drugs Revenue Share by Company (2016-2021)
    Table 16. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2020)
    Table 17. Global Parenteral Drugs Average Price (USD/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Parenteral Drugs Manufacturing Sites and Area Served
    Table 19. Manufacturers Parenteral Drugs Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Parenteral Drugs Sales (K Units)  (2016-2021)
    Table 22. Global Parenteral Drugs Sales Share  (2016-2021)
    Table 23. Global Parenteral Drugs Revenue (US$ Million) Market Share  (2016-2021)
    Table 24. Global Parenteral Drugs Price (USD/Unit)  (2016-2021)
    Table 25. Global Parenteral Drugs Sales Share  (2022-2027)
    Table 26. Global Parenteral Drugs Revenue (US$ Million) Market Share  (2022-2027) 
    Table 27. Global Parenteral Drugs Revenue Share  (2022-2027)
    Table 28. Global Parenteral Drugs Price (USD/Unit)  (2022-2027)
    Table 29. Global Parenteral Drugs Sales (K Units)  (2016-2021) 
    Table 30. Global Parenteral Drugs Sales Share  (2016-2021)
    Table 31. Global Parenteral Drugs Revenue (US$ Million) Market Share  (2016-2021)
    Table 32. Global Parenteral Drugs Price (USD/Unit)  (2016-2021)
    Table 33. Global Parenteral Drugs Sales (K Units)  (2022-2027)
    Table 34. Global Parenteral Drugs Sales Share  (2022-2027)
    Table 35. Global Parenteral Drugs Revenue (US$ Million) Market Share  (2022-2027)
    Table 36. Global Parenteral Drugs Revenue Share  (2022-2027)
    Table 37. Global Parenteral Drugs Price (USD/Unit)  (2022-2027)
    Table 38. North America Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 39. North America Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 40. North America Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 42. North America Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 43. North America Parenteral Drugs Sales Market Share  (2016-2021)
    Table 44. North America Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 45. North America Parenteral Drugs Sales Market Share  (2022-2027)
    Table 46. North America Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 47. North America Parenteral Drugs Sales Market Share  (2016-2021)
    Table 48. North America Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 49. North America Parenteral Drugs Sales Market Share  (2022-2027)
    Table 50. Europe Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 51. Europe Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 52. Europe Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 54. Europe Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 55. Europe Parenteral Drugs Sales Market Share  (2016-2021)
    Table 56. Europe Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 57. Europe Parenteral Drugs Sales Market Share  (2022-2027)
    Table 58. Europe Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 59. Europe Parenteral Drugs Sales Market Share  (2016-2021)
    Table 60. Europe Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 61. Europe Parenteral Drugs Sales Market Share  (2022-2027)
    Table 62. China Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 63. China Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 64. China Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 66. China Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 67. China Parenteral Drugs Sales Market Share  (2016-2021)
    Table 68. China Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 69. China Parenteral Drugs Sales Market Share  (2022-2027)
    Table 70. China Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 71. China Parenteral Drugs Sales Market Share  (2016-2021)
    Table 72. China Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 73. China Parenteral Drugs Sales Market Share  (2022-2027)
    Table 74. Japan Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 75. Japan Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 76. Japan Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 78. Japan Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 79. Japan Parenteral Drugs Sales Market Share  (2016-2021)
    Table 80. Japan Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 81. Japan Parenteral Drugs Sales Market Share  (2022-2027)
    Table 82. Japan Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 83. Japan Parenteral Drugs Sales Market Share  (2016-2021)
    Table 84. Japan Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 85. Japan Parenteral Drugs Sales Market Share  (2022-2027)
    Table 86. Southeast Asia Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 91. Southeast Asia Parenteral Drugs Sales Market Share  (2016-2021)
    Table 92. Southeast Asia Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 93. Southeast Asia Parenteral Drugs Sales Market Share  (2022-2027)
    Table 94. Southeast Asia Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 95. Southeast Asia Parenteral Drugs Sales Market Share  (2016-2021)
    Table 96. Southeast Asia Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 97. Southeast Asia Parenteral Drugs Sales Market Share  (2022-2027)
    Table 98. India Parenteral Drugs Sales (K Units) by Company (2016-2021)
    Table 99. India Parenteral Drugs Sales Market Share by Company (2016-2021)
    Table 100. India Parenteral Drugs Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Parenteral Drugs Revenue Market Share by Company (2016-2021)
    Table 102. India Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 103. India Parenteral Drugs Sales Market Share  (2016-2021)
    Table 104. India Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 105. India Parenteral Drugs Sales Market Share  (2022-2027)
    Table 106. India Parenteral Drugs Sales  (2016-2021) & (K Units)
    Table 107. India Parenteral Drugs Sales Market Share  (2016-2021)
    Table 108. India Parenteral Drugs Sales  (2022-2027) & (K Units)
    Table 109. India Parenteral Drugs Sales Market Share  (2022-2027)
    Table 110. Ostuka Pharmaceutical Corporation Information
    Table 111. Ostuka Pharmaceutical Description and Business Overview
    Table 112. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 113. Ostuka Pharmaceutical Parenteral Drugs Product
    Table 114. Ostuka Pharmaceutical Recent Development
    Table 115. Teva Pharmaceutical Industries Corporation Information
    Table 116. Teva Pharmaceutical Industries Description and Business Overview
    Table 117. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 118. Teva Pharmaceutical Industries Parenteral Drugs Product
    Table 119. Teva Pharmaceutical Industries Recent Development
    Table 120. Kelun Pharma Corporation Information
    Table 121. Kelun Pharma Description and Business Overview
    Table 122. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 123. Kelun Pharma Parenteral Drugs Product
    Table 124. Kelun Pharma Recent Development
    Table 125. Cook Pharmica Corporation Information
    Table 126. Cook Pharmica Description and Business Overview
    Table 127. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 128. Cook Pharmica Parenteral Drugs Product
    Table 129. Cook Pharmica Recent Development
    Table 130. Patheon Corporation Information
    Table 131. Patheon Description and Business Overview
    Table 132. Patheon Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 133. Patheon Parenteral Drugs Product
    Table 134. Patheon Recent Development
    Table 135. BAG Healthcare Corporation Information
    Table 136. BAG Healthcare Description and Business Overview
    Table 137. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 138. BAG Healthcare Parenteral Drugs Product
    Table 139. BAG Healthcare Recent Development
    Table 140. Beximco Pharma Corporation Information
    Table 141. Beximco Pharma Description and Business Overview
    Table 142. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 143. Beximco Pharma Parenteral Drugs Product
    Table 144. Beximco Pharma Recent Development
    Table 145. Baxter Healthcare Corporation Corporation Information
    Table 146. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 147. Baxter Healthcare Corporation Description and Business Overview
    Table 148. Baxter Healthcare Corporation Parenteral Drugs Product
    Table 149. Baxter Healthcare Corporation Recent Development
    Table 150. B. Braun Corporation Information
    Table 151. B. Braun Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 152. B. Braun Description and Business Overview
    Table 153. B. Braun Parenteral Drugs Product
    Table 154. B. Braun Recent Development
    Table 155. Fresenius Corporation Information
    Table 156. Fresenius Description and Business Overview
    Table 157. Fresenius Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 158. Fresenius Parenteral Drugs Product
    Table 159. Fresenius Recent Development
    Table 160. Albert David Corporation Information
    Table 161. Albert David Description and Business Overview
    Table 162. Albert David Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 163. Albert David Parenteral Drugs Product
    Table 164. Albert David Recent Development
    Table 165. BML Parenteral Drugs Corporation Information
    Table 166. BML Parenteral Drugs Description and Business Overview
    Table 167. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 168. BML Parenteral Drugs Parenteral Drugs Product
    Table 169. BML Parenteral Drugs Recent Development
    Table 170. Pfizer (Hospira) Corporation Information
    Table 171. Pfizer (Hospira) Description and Business Overview
    Table 172. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 173. Pfizer (Hospira) Parenteral Drugs Product
    Table 174. Pfizer (Hospira) Recent Development
    Table 175. Pisa Corporation Information
    Table 176. Pisa Description and Business Overview
    Table 177. Pisa Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 178. Pisa Parenteral Drugs Product
    Table 179. Pisa Recent Development
    Table 180. Ozon Pharmaceuticals Ltd Corporation Information
    Table 181. Ozon Pharmaceuticals Ltd Description and Business Overview
    Table 182. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 183. Ozon Pharmaceuticals Ltd Parenteral Drugs Product
    Table 184. Ozon Pharmaceuticals Ltd Recent Development
    Table 185. Aspen Holdings Corporation Information
    Table 186. Aspen Holdings Description and Business Overview
    Table 187. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 188. Aspen Holdings Parenteral Drugs Product
    Table 189. Aspen Holdings Recent Development
    Table 190. PSI Ltd Corporation Information
    Table 191. PSI Ltd Description and Business Overview
    Table 192. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 193. PSI Ltd Parenteral Drugs Product
    Table 194. PSI Ltd Recent Development
    Table 195. Wintac Limited Corporation Information
    Table 196. Wintac Limited Description and Business Overview
    Table 197. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 198. Wintac Limited Parenteral Drugs Product
    Table 199. Wintac Limited Recent Development
    Table 200. AXA Parenterals Ltd Corporation Information
    Table 201. AXA Parenterals Ltd Description and Business Overview
    Table 202. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 203. AXA Parenterals Ltd Parenteral Drugs Product
    Table 204. AXA Parenterals Ltd Recent Development
    Table 205. Acebright Corporation Information
    Table 206. Acebright Description and Business Overview
    Table 207. Acebright Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 208. Acebright Parenteral Drugs Product
    Table 209. Acebright Recent Development
    Table 210. Southwest Pharmaceutical Corporation Information
    Table 211. Southwest Pharmaceutical Description and Business Overview
    Table 212. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 213. Southwest Pharmaceutical Parenteral Drugs Product
    Table 214. Southwest Pharmaceutical Recent Development
    Table 215. Abbott Corporation Information
    Table 216. Abbott Description and Business Overview
    Table 217. Abbott Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 218. Abbott Parenteral Drugs Product
    Table 219. Abbott Recent Development
    Table 220. Production Base and Market Concentration Rate of Raw Material
    Table 221. Key Suppliers of Raw Materials
    Table 222. Parenteral Drugs Distributors List
    Table 223. Parenteral Drugs Customers List
    Table 224. Parenteral Drugs Market Trends
    Table 225. Parenteral Drugs Market Drivers
    Table 226. Parenteral Drugs Market Challenges
    Table 227. Parenteral Drugs Market Restraints
    Table 228. Research Programs/Design for This Report
    Table 229. Key Data Information from Secondary Sources
    Table 230. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parenteral Drugs Product Picture
    Figure 2. Global Parenteral Drugs Sales Market Share  in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Parenteral Drugs Sales Market Share  in 2021 & 2027
    Figure 6. Hospitals Examples
    Figure 7. Medical Centers Examples
    Figure 8. Others Examples
    Figure 9. Global Parenteral Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Parenteral Drugs Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 11. Global Parenteral Drugs Sales (K Units) Growth Rate (2016-2027)
    Figure 12. Global Parenteral Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
    Figure 13. Global Parenteral Drugs Revenue Market Share by Region: 2016 VS 2021
    Figure 14. Global Parenteral Drugs Revenue Market Share by Region: 2021 VS 2027
    Figure 15. North America Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 16. North America Parenteral Drugs Sales (K Units) Growth Rate (2016-2027)
    Figure 17. Europe Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 18. Europe Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 19. China Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 20. China Parenteral Drugs Sales (Million USD) and Growth Rate (2016-2027)
    Figure 21. Japan Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 22. Japan Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 25. India Parenteral Drugs Revenue (Million USD) Growth Rate (2016-2027)
    Figure 26. India Parenteral Drugs Sales (Million USD) Growth Rate (2016-2027)
    Figure 27. Global 5 Largest Parenteral Drugs Players Market Share by Revenue in Parenteral Drugs: 2016 & 2020
    Figure 28. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 29. Global Parenteral Drugs Revenue Share  (2016-2021)
    Figure 30. Global Parenteral Drugs Revenue Growth Rate  in 2016 & 2020
    Figure 31. Global Parenteral Drugs Revenue Share  (2016-2021)
    Figure 32. Global Parenteral Drugs Revenue Growth Rate  in 2016 & 2020
    Figure 33. North America Parenteral Drugs Sales Market Share  in 2020
    Figure 34. North America Parenteral Drugs Sales Market Share  in 2020
    Figure 35. Europe Parenteral Drugs Sales Market Share  in 2020
    Figure 36. Europe Parenteral Drugs Sales Market Share  in 2020
    Figure 37. China Parenteral Drugs Sales Market Share  in 2020
    Figure 38. China Parenteral Drugs Sales Market Share  in 2020
    Figure 39. Japan Parenteral Drugs Sales Market Share  in 2020
    Figure 40. Japan Parenteral Drugs Sales Market Share  in 2020
    Figure 41. Southeast Asia Parenteral Drugs Sales Market Share  in 2020
    Figure 42. Southeast Asia Parenteral Drugs Sales Market Share  in 2020
    Figure 43. India Parenteral Drugs Sales Market Share  in 2020
    Figure 44. India Parenteral Drugs Sales Market Share  in 2020
    Figure 45. Key Raw Materials Price Trend
    Figure 46. Manufacturing Cost Structure of Parenteral Drugs 
    Figure 47. Manufacturing Process Analysis of Parenteral Drugs
    Figure 48. Parenteral Drugs Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation 
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Frequently Asked Questions
Parenteral Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parenteral Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parenteral Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tubing Bundles

The global Tubing Bundles market is segmented by company, region (country), , and . Players, stak ... Read More